Terence Flynn
Stock Analyst at Morgan Stanley
(4.76)
# 618
Out of 4,668 analysts
1068
Total ratings
62.5%
Success rate
12%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Hold | $351 → $362 | $433.73 | -16.54% | 56 | Aug 19, 2026 | |
| MRK Merck & Co. | Upgraded: Buy | $116 → $179 | $148.99 | +20.14% | 56 | Aug 19, 2026 | |
| MRNA Moderna | Maintained: Hold | $39 → $89 | $133.32 | -33.24% | 37 | Aug 19, 2026 | |
| BNTX BioNTech SE | Rated: Buy | $115 | $110.89 | +3.71% | 88 | Aug 17, 2026 | |
| ALMS Alumis | Rated: Buy | $39 | $22.86 | +70.60% | 10 | Aug 17, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Sell | $40 | $65.47 | -38.90% | 50 | Aug 14, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $48 | $21.26 | +125.78% | 8 | Aug 12, 2026 | |
| BHVN Biohaven | Rated: Buy | $18 | $13.50 | +33.33% | 19 | Aug 12, 2026 | |
| NTLA Intellia Therapeutics | Rated: Hold | $15 | $12.44 | +20.58% | 19 | Aug 10, 2026 | |
| RCUS Arcus Biosciences | Rated: Hold | $22 → $23 | $29.52 | -22.09% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $11 → $10 | $9.03 | +10.80% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.24 | - | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 | $50.52 | +149.41% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,347 → $1,419 | $1,244.40 | +14.03% | 80 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $516 → $515 | $521.00 | -1.15% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $64 → $65 | $60.58 | +7.30% | 30 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 | $143.44 | +15.03% | 62 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $27.79 | +0.76% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $294 | $267.37 | +9.96% | 58 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $278 → $296 | $261.83 | +13.05% | 54 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $730 → $758 | $826.64 | -8.30% | 60 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $222 → $231 | $214.35 | +7.77% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $38 | $27.05 | +40.48% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $612 → $616 | $540.26 | +14.02% | 52 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $13.74 | -34.50% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $32 → $33 | $58.12 | -43.22% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.03 | - | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.94 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16 | $48.02 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $12 | $3.29 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €90.70 | €138.05 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $41.69 | $9.41 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $109.51 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 → $155 | $229.30 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $78.47 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $7.32 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $33.63 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $9.38 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $4.57 | n/a | 1 | Jul 21, 2015 |
Amgen
Aug 19, 2026
Maintained: Hold
Price Target: $351 → $362
Current: $433.73
Upside: -16.54%
Merck & Co.
Aug 19, 2026
Upgraded: Buy
Price Target: $116 → $179
Current: $148.99
Upside: +20.14%
Moderna
Aug 19, 2026
Maintained: Hold
Price Target: $39 → $89
Current: $133.32
Upside: -33.24%
BioNTech SE
Aug 17, 2026
Rated: Buy
Price Target: $115
Current: $110.89
Upside: +3.71%
Alumis
Aug 17, 2026
Rated: Buy
Price Target: $39
Current: $22.86
Upside: +70.60%
Bristol-Myers Squibb Company
Aug 14, 2026
Maintained: Sell
Price Target: $40
Current: $65.47
Upside: -38.90%
Legend Biotech
Aug 12, 2026
Maintained: Buy
Price Target: $48
Current: $21.26
Upside: +125.78%
Biohaven
Aug 12, 2026
Rated: Buy
Price Target: $18
Current: $13.50
Upside: +33.33%
Intellia Therapeutics
Aug 10, 2026
Rated: Hold
Price Target: $15
Current: $12.44
Upside: +20.58%
Arcus Biosciences
Aug 10, 2026
Rated: Hold
Price Target: $22 → $23
Current: $29.52
Upside: -22.09%
Aug 10, 2026
Rated: Hold
Price Target: $11 → $10
Current: $9.03
Upside: +10.80%
Aug 10, 2026
Rated: Hold
Price Target: n/a
Current: $3.24
Upside: -
Aug 10, 2026
Rated: Buy
Price Target: $126
Current: $50.52
Upside: +149.41%
Aug 6, 2026
Reiterated: Buy
Price Target: $1,347 → $1,419
Current: $1,244.40
Upside: +14.03%
Aug 6, 2026
Rated: Hold
Price Target: $516 → $515
Current: $521.00
Upside: -1.15%
Aug 6, 2026
Rated: Buy
Price Target: $64 → $65
Current: $60.58
Upside: +7.30%
Aug 5, 2026
Maintained: Buy
Price Target: $165
Current: $143.44
Upside: +15.03%
Aug 4, 2026
Maintained: Hold
Price Target: $28
Current: $27.79
Upside: +0.76%
Aug 3, 2026
Maintained: Buy
Price Target: $294
Current: $267.37
Upside: +9.96%
Aug 3, 2026
Rated: Buy
Price Target: $278 → $296
Current: $261.83
Upside: +13.05%
Jul 31, 2026
Maintained: Hold
Price Target: $730 → $758
Current: $826.64
Upside: -8.30%
Jul 30, 2026
Maintained: Hold
Price Target: $222 → $231
Current: $214.35
Upside: +7.77%
Jul 28, 2026
Rated: Buy
Price Target: $36 → $38
Current: $27.05
Upside: +40.48%
May 5, 2026
Rated: Buy
Price Target: $612 → $616
Current: $540.26
Upside: +14.02%
Apr 10, 2026
Maintained: Hold
Price Target: $9
Current: $13.74
Upside: -34.50%
Feb 17, 2026
Maintained: Sell
Price Target: $32 → $33
Current: $58.12
Upside: -43.22%
Sep 21, 2025
Maintained: Hold
Price Target: n/a
Current: $4.03
Upside: -
Dec 13, 2024
Maintained: Hold
Price Target: n/a
Current: $2.94
Upside: n/a
Jun 1, 2021
Maintained: Sell
Price Target: $16
Current: $48.02
Upside: n/a
Aug 10, 2020
Maintained: Hold
Price Target: $21 → $12
Current: $3.29
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €90.70
Current: €138.05
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $41.69
Current: $9.41
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $109.51
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $163 → $155
Current: $229.30
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $78.47
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $7.32
Upside: n/a
Jun 13, 2016
Maintained: Hold
Price Target: $46
Current: $33.63
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $9.38
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $4.57
Upside: n/a